August 5, 1997: Alternative Cancer Treatments - Bob Guccione
The Art Bell Archive · Arthur William Bell III
November 13, 202340m 35s
Audio is streamed directly from the publisher (archive.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Art Bell speaks with Penthouse Magazine publisher Bob Guccione about his wife Kathy Keaton's remarkable recovery from terminal stage four breast cancer. Diagnosed two years earlier with cancer that had spread throughout her lymph nodes, liver, stomach, and bones, Kathy was given three to six weeks to live. She refused chemotherapy and radiation, instead choosing hydrazine sulfate, an inexpensive compound Penthouse had investigated for 18 years.
Bob details how hydrazine sulfate combats cachexia, the wasting process that ultimately kills cancer patients, while also shrinking tumors. He describes flying staff to Japan and Italy to obtain vitamin K3, a complementary treatment unavailable in the United States due to pharmaceutical industry resistance. He reports that Kathy is now in complete remission and healthier than ever, at a treatment cost of roughly $150 per year compared to tens of thousands for conventional therapy.
Bob describes how the National Cancer Institute sabotaged UCLA clinical trials by administering incompatible substances to 600 patients, then declared hydrazine sulfate ineffective. He announces plans for a class action lawsuit and urges families of the trial participants to contact Penthouse with their stories.
Bob details how hydrazine sulfate combats cachexia, the wasting process that ultimately kills cancer patients, while also shrinking tumors. He describes flying staff to Japan and Italy to obtain vitamin K3, a complementary treatment unavailable in the United States due to pharmaceutical industry resistance. He reports that Kathy is now in complete remission and healthier than ever, at a treatment cost of roughly $150 per year compared to tens of thousands for conventional therapy.
Bob describes how the National Cancer Institute sabotaged UCLA clinical trials by administering incompatible substances to 600 patients, then declared hydrazine sulfate ineffective. He announces plans for a class action lawsuit and urges families of the trial participants to contact Penthouse with their stories.